Edition:
United Kingdom

Fate Therapeutics Inc (FATE.OQ)

FATE.OQ on NASDAQ Stock Exchange Global Market

11.63USD
16 Jul 2018
Change (% chg)

$-0.23 (-1.94%)
Prev Close
$11.86
Open
$11.88
Day's High
$12.00
Day's Low
$11.49
Volume
62,127
Avg. Vol
203,159
52-wk High
$14.45
52-wk Low
$2.54

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month
Last Updated
Outperform -0.27 December 17 Jul 2018

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago
2 Month
Ago
3 Month
Ago
(1) BUY 2 2 2 2
(2) OUTPERFORM 2 2 2 2
(3) HOLD 2 2 2 2
(4) UNDERPERFORM 0 0 0 0
(5) SELL 0 0 0 0
No Opinion 0 0 0 0
Mean Rating 2.00 2.00 2.00 2.00

Consensus Estimates Analysis

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Quarter Ending Sep-18 6 1.01 2.00 0.00 1.90
Quarter Ending Dec-18 6 1.01 2.00 0.00 2.43
Year Ending Dec-18 6 4.25 7.10 2.05 7.24
Year Ending Dec-19 6 2.29 4.10 0.00 10.94
Earnings (per share)
Quarter Ending Sep-18 6 -0.27 -0.18 -0.31 -0.24
Quarter Ending Dec-18 6 -0.27 -0.19 -0.32 -0.24
Year Ending Dec-18 6 -1.07 -0.82 -1.19 -0.95
Year Ending Dec-19 6 -1.14 -0.79 -1.48 -0.83

Historical Surprises

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Estimates vs Actual Estimate Actual Difference Surprise %
SALES (in millions)
Quarter Ending Mar-18 1.68 1.06 0.62 36.92
Quarter Ending Dec-17 0.94 1.03 0.09 9.24
Quarter Ending Sep-17 0.94 1.03 0.08 8.86
Quarter Ending Jun-17 0.94 1.03 0.09 9.55
Quarter Ending Mar-17 0.95 1.03 0.08 8.47
Earnings (per share)
Quarter Ending Mar-18 -0.22 -0.27 0.05 -20.91
Quarter Ending Dec-17 -0.24 -0.29 0.05 -18.71
Quarter Ending Sep-17 -0.24 -0.26 0.02 -7.57
Quarter Ending Jun-17 -0.24 -0.23 0.01 -4.17
Quarter Ending Mar-17 -0.20 -0.24 0.04 -17.65

Consensus Estimates Trend

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  Current 1 Week
Ago
1 Month
Ago
2 Month
Ago
1 Year
Ago
SALES (in millions)
Quarter Ending Sep-18 1.01 1.01 1.01 1.01 1.90
Quarter Ending Dec-18 1.01 1.01 1.01 1.01 2.43
Year Ending Dec-18 4.25 4.25 4.25 4.25 7.24
Year Ending Dec-19 2.29 2.29 2.29 2.29 10.94
Earnings (per share)
Quarter Ending Sep-18 -0.27 -0.27 -0.27 -0.26 -0.24
Quarter Ending Dec-18 -0.27 -0.27 -0.27 -0.27 -0.24
Year Ending Dec-18 -1.07 -1.07 -1.07 -1.05 -0.95
Year Ending Dec-19 -1.14 -1.14 -1.14 -1.13 -0.83

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Quarter Ending Sep-18 0 0 0 0
Quarter Ending Dec-18 0 0 0 0
Year Ending Dec-18 0 0 0 0
Year Ending Dec-19 0 0 0 0
Earnings
Quarter Ending Sep-18 0 0 0 0
Quarter Ending Dec-18 0 0 0 0
Year Ending Dec-18 0 0 0 0
Year Ending Dec-19 0 0 0 0